DK3548044T3 - Arsenic compositions - Google Patents

Arsenic compositions Download PDF

Info

Publication number
DK3548044T3
DK3548044T3 DK17876251.4T DK17876251T DK3548044T3 DK 3548044 T3 DK3548044 T3 DK 3548044T3 DK 17876251 T DK17876251 T DK 17876251T DK 3548044 T3 DK3548044 T3 DK 3548044T3
Authority
DK
Denmark
Prior art keywords
arsenic
compositions
arsenic compositions
Prior art date
Application number
DK17876251.4T
Other languages
English (en)
Inventor
Malvin Eutick
Original Assignee
Eupharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016904945A external-priority patent/AU2016904945A0/en
Application filed by Eupharma Pty Ltd filed Critical Eupharma Pty Ltd
Application granted granted Critical
Publication of DK3548044T3 publication Critical patent/DK3548044T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/36Arsenic; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK17876251.4T 2016-12-01 2017-08-02 Arsenic compositions DK3548044T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016904945A AU2016904945A0 (en) 2016-12-01 Arsenic compositions
PCT/AU2017/050807 WO2018098519A1 (en) 2016-12-01 2017-08-02 Arsenic compositions

Publications (1)

Publication Number Publication Date
DK3548044T3 true DK3548044T3 (en) 2023-12-11

Family

ID=62240940

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17876251.4T DK3548044T3 (en) 2016-12-01 2017-08-02 Arsenic compositions

Country Status (20)

Country Link
US (1) US11241453B2 (da)
EP (1) EP3548044B1 (da)
JP (2) JP7080230B2 (da)
KR (1) KR102487884B1 (da)
CN (1) CN109952105A (da)
AU (1) AU2017368444B9 (da)
BR (1) BR112019007498A2 (da)
CA (1) CA3041357A1 (da)
CL (1) CL2019001422A1 (da)
DK (1) DK3548044T3 (da)
ES (1) ES2964979T3 (da)
IL (1) IL265986B (da)
MX (1) MX2019006107A (da)
NZ (1) NZ752214A (da)
PE (1) PE20191544A1 (da)
PL (1) PL3548044T3 (da)
SG (1) SG11201903064SA (da)
TW (1) TWI808060B (da)
WO (1) WO2018098519A1 (da)
ZA (1) ZA201902156B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017305945B2 (en) 2016-08-01 2019-11-21 Veolia Water Solutions & Technologies Support Process for removing silica from produced water and other wastewater streams
WO2018098519A1 (en) * 2016-12-01 2018-06-07 Eupharma Pty Ltd Arsenic compositions
CA3211092A1 (en) * 2021-02-26 2022-09-01 Intas Pharmaceuticals Ltd. Oral pharmaceutical composition of arsenic trioxide
JP2022151442A (ja) * 2021-03-26 2022-10-07 均 石井 白血病治療薬。

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2080004A (en) * 1933-05-17 1937-05-11 Frederick E Dearborn Double salt of copper arsenite and a copper salt of an unsaturated fatty acid and process of making the same
US3280046A (en) 1963-03-27 1966-10-18 Dow Chemical Co Polyol ether resins and utility
KR20010015755A (ko) 1997-10-15 2001-02-26 폴락스 바이오파르마큐티칼스 인코포레이티드 비소 화합물을 이용하여 1차 신형성 질환 및 전이성신형성 질환을 치료하는 조성물 및 방법
EP2255800B1 (en) 1997-11-10 2012-10-17 Memorial Sloan Kettering Cancer Center Arsenic trioxide for use in the treatment of leukaemia
CN1471925A (zh) * 2002-08-02 2004-02-04 丛繁滋 更适于硬质肿瘤直接给药的含砷组合物、制剂及制备方法
US7521071B2 (en) 2002-10-09 2009-04-21 Versitech Limited Formulation of oral compositions comprising arsenic trioxide and methods of use thereof
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
CN102060722B (zh) * 2009-05-01 2014-06-11 常州高新技术产业开发区三维工业技术研究所有限公司 一种含砷化合物及其制备方法和用途
EP2359812A1 (en) 2010-01-18 2011-08-24 Cephalon France Oral lyophilised compositions
CN105435228B (zh) * 2014-08-14 2020-08-07 中国科学院上海营养与健康研究所 三氧化二砷的抗肿瘤新用途及抗肿瘤制剂
SG11201706150QA (en) * 2015-01-29 2017-08-30 Eupharma Pty Ltd Compositions containing arsenic and their use in methods of treatment
AU2016211186A1 (en) 2015-02-01 2017-08-17 Syros Pharmaceuticals, Inc. High surface-area lyophilized compositions comprising arsenic for oral administration in patients
WO2018098519A1 (en) 2016-12-01 2018-06-07 Eupharma Pty Ltd Arsenic compositions

Also Published As

Publication number Publication date
JP2020500845A (ja) 2020-01-16
EP3548044A4 (en) 2020-07-22
AU2017368444B9 (en) 2020-07-02
CA3041357A1 (en) 2018-06-07
JP2022069485A (ja) 2022-05-11
ZA201902156B (en) 2021-01-27
JP7080230B2 (ja) 2022-06-03
TW201821087A (zh) 2018-06-16
US20200016196A1 (en) 2020-01-16
SG11201903064SA (en) 2019-05-30
US11241453B2 (en) 2022-02-08
KR102487884B1 (ko) 2023-01-11
IL265986A (en) 2019-06-30
IL265986B (en) 2022-09-01
AU2017368444A1 (en) 2019-04-18
WO2018098519A1 (en) 2018-06-07
KR20190089865A (ko) 2019-07-31
BR112019007498A2 (pt) 2019-07-02
JP7419415B2 (ja) 2024-01-22
PL3548044T3 (pl) 2024-03-04
PE20191544A1 (es) 2019-10-24
AU2017368444B2 (en) 2020-04-30
MX2019006107A (es) 2019-08-21
CN109952105A (zh) 2019-06-28
EP3548044B1 (en) 2023-09-20
NZ752214A (en) 2022-11-25
ES2964979T3 (es) 2024-04-10
EP3548044A1 (en) 2019-10-09
TWI808060B (zh) 2023-07-11
CL2019001422A1 (es) 2019-08-02

Similar Documents

Publication Publication Date Title
IL261792B (en) Preparations
IL260933A (en) Preparations containing tocorsol or its analogues
GB2573068B (en) Antimicrobial Compositions
GB201610156D0 (en) Cliptac compositions
IL265986A (en) Arsenic compounds
PL3253232T3 (pl) Kompozycje przeciwdrobnoustrojowe
GB201607814D0 (en) Anti-microbial compositions
GB201610264D0 (en) Pesticidal compositions
GB201600075D0 (en) Immunogenci composition
GB201614799D0 (en) Compositions
GB201607699D0 (en) Anti-microbial compositions
GB201622161D0 (en) Compositions
EP3443034C0 (en) COMPOSITION
ZA201706948B (en) Antibacterial compositions
GB201612359D0 (en) Composition
GB201611782D0 (en) Composition
ZA201706947B (en) Antibacterial compositions
PL3462873T3 (pl) Kompozycje fungicydowe
GB201602658D0 (en) Compositions
GB201607924D0 (en) Composition
AU2016904945A0 (en) Arsenic compositions
GB201621050D0 (en) Antimicrobial compositions
GB201614230D0 (en) Compositions
GB201611960D0 (en) Compositions
GB201611851D0 (en) Compositions